Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Septin-10 (SEPTIN10) is a member of the septin family of cytoskeletal proteins that possess GTPase activity and can form filaments and higher-order oligomeric complexes[3][4][6]. These proteins localize to the cytoplasm and nucleus, contributing to processes such as cytokinesis, cytoskeletal organization, and cell division[3][4][6]. Septins, including Septin-10, interact with cellular membranes, actin filaments, and microtubules, and their assembly is regulated by nucleotide binding, post-translational modifications, and interaction with other proteins and cytoskeletal elements[1][4]. SEPTIN10 is implicated in a range of physiological and pathological processes, including the development and function of neurons, morphogenesis, and pathological conditions like cancer, neurodevelopmental disorders, and infertility[1][2][4]. There are currently no known drugs directly targeting Septin-10, and its therapeutic targeting remains unexplored[1][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Septin-10 (SEPTIN10).